UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer

Clinical trial NCT05148767 · RECRUITING

Trial details

NCT number: NCT05148767
Sponsor: Zhejiang Cancer Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Rectal Cancer Stage III

Start date: 2022-01-01
Primary completion: 2026-06-01
Enrollment: 606

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.